Casanova MJ, Nantes O, Varela P, Vela-Gonzalez M, et al. Real-world outcomes of switching from adalimumab originator to adalimumab biosimilar in patients with inflammatory bowel disease: The ADA-SWITCH study. Aliment Pharmacol Ther 2023 Apr 23. doi: 10.1111/apt.17525.
PMID: 37089065